Solid Biosciences Inc.

SLDB | NASDAQ

Price Alert Chart Builder DCF Calculator

$8.91

+$0.37 (+4.33%)

Sep 22, 2026, 2:07 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-174.33M	-124.7M	-96.02M	-85.98M	-72.19M	-88.29M
Depreciation & Amortization	-1.87M	2.46M	2.58M	2.41M	2.96M	3.92M
Stock-Based Compensation	16.91M	10.52M	7.63M	7.54M	13.37M	11.63M
Other Working Capital	-5.73M	645K	-5.57M	1.45M	-12.64M	19.59M
Other Non-Cash Items	9.82M	8.86M	-2.03M	-18.25M	-81K	-20K
Deferred Income Tax	n/a	n/a	n/a	n/a	1.21M	n/a
Change in Working Capital	-6.82M	2.85M	-6.34M	-3.69M	-23.04M	16.16M
Operating Cash Flow	-156.29M	-100.01M	-94.18M	-97.98M	-77.76M	-56.6M
Capital Expenditures	-1.15M	-654K	-1.52M	-3.02M	-1.28M	-899K
Cash Acquisitions	85K	5K	n/a	31.52M	89.81M	-7.5M
Purchase of Investments	-235.89M	-204.34M	-117.43M	-182.76M	-141.25M	-401K
Sales Maturities Of Investments	178.5M	188.9M	128.63M	212.81M	51.44M	7.9M
Other Investing Acitivies	n/a	n/a	n/a	600K	-89.81M	7.5M
Investing Cash Flow	-58.45M	-16.09M	9.69M	59.16M	-91.09M	6.6M
Debt Repayment	-723K	-473K	n/a	2.08M	n/a	n/a
Common Stock Repurchased	n/a	-5.11M	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	425K	794K	148K	203K	107K	n/a
Financial Cash Flow	194.45M	122.44M	3.12M	74.83M	134.99M	128.7M
Net Cash Flow	-20.3M	6.34M	-81.37M	36.01M	-33.87M	78.7M
Free Cash Flow	-157.44M	-100.67M	-95.7M	-100.99M	-79.05M	-57.5M
Adj. Free Cash Flow	-174.36M	-111.19M	-103.32M	-108.53M	-92.42M	-69.13M
Maintenance CapEx	-1.15M	-654K	-1.52M	-3.02M	n/a	-899K
Growth CapEx	n/a	n/a	n/a	n/a	-1.28M	n/a
Owner Earnings	-157.44M	-100.67M	-95.7M	-100.99M	-77.76M	-57.5M